| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.03 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |